4.5 Article

Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents

Journal

BMC PEDIATRICS
Volume 12, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1471-2431-12-108

Keywords

West syndrome; Encephalopathic epilepsy; ACTH; Vigabatrin; Infantile spasms; Treatment; Continuum of care; Community resources; Seizures; Infants

Categories

Funding

  1. Questcor Pharmaceuticals, Union City, CA
  2. NIH
  3. Shainberg Foundation
  4. UCB
  5. Ovation
  6. Questcor
  7. Marinus
  8. Ortho-McNeil
  9. King
  10. Cyberonics
  11. Eisai
  12. Valeant
  13. GlaxoSmithKline
  14. Questcor Pharmaceuticals
  15. Lundbeck
  16. Novartis Oncology
  17. UCB, and Cyberonics

Ask authors/readers for more resources

Background: Infantile spasms (IS; West syndrome) is a severe form of encephalopathy that typically affects infants younger than 2 years old. Pediatricians, pediatric neurologists, and other pediatric health care providers are all potentially key early contacts for families who have an infant with IS. The objective of this article is to assist pediatric health care providers in the detection of the disease and in the counseling and guidance of families who have an infant with IS. Methods: Treatment guidelines, consensus reports, and original research studies are reviewed to provide an update regarding the diagnosis and treatment of infants with IS. Web sites were searched for educational and supportive resource content relevant to providers and families of patients with IS. Results: Early detection of IS and pediatrician referral to a pediatric neurologist for further evaluation and initiation of treatment may improve prognosis. Family education and the establishment of a multidisciplinary continuum of care are important components of care for the majority of patients with IS. The focus of the continuum of care varies across diagnosis, initiation of treatment, and short- and long-term needs. Several on-line educational and supportive resources for families and caregivers of patients with IS were identified. Conclusions: Given the possibility of poor developmental outcomes in IS, including the emergence of other seizure disorders and cognitive and developmental problems, early recognition, referral, and treatment of IS are important for optimal patient outcomes. Dissemination of and access to educational and supportive resources for families and caregivers across the lifespan of the child with IS is an urgent need. Pediatric health care providers are well positioned to address these needs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available